00:37:44	Andras Dinnyes:	Hi From Hungary, BioTalentum Ltd
00:37:44	Paul Strumph:	Hello all, such a pleasure to attend. I am a diabetes clinical development consultant
00:37:50	Neil Clegg Vancouver Bio Conscious:	Neil Clegg from Bio Conscious in Vancouver, BC, Canada
00:37:50	ThomasDiLenge:	Hi, thanks for this great panel!  I'm Tom DiLenge, from Flagship Pioneering.  And great to see Janet again!
00:38:03	David Wood:	Hi, Pleasure to be attending from London (UK). I have the privilege to serve as Executive Director of Longevity Escape Velocity Foundation
00:38:18	Fang Li:	Hi Zen, Tim: Good to see you! I enjoy this annual tradition and look forward to getting your perspectives especially at this time!
00:38:50	Monica Feldman - Perceptrack:	Hi, Monica Feldman from Longevity Ruler in Sun City, Arizona
00:39:30	Kanwaljit Singh:	Hello, good morning, logging in from Critical Path Institute in Tucson, AZ.
00:40:05	wei shen:	Hi This is Wei Shen from Immunomic Therapeutics. Very happy to attend this panel! Can't wait for the discussion!
00:40:18	Ron Bartek:	Ron Bartek, Co-Founder/President Friedreich's Ataxia Research Alliance (FARA); Alliance for a Stronger FDA Board of Directors
00:45:34	Anderson, Margaret:	ORCHIDS! Margaret Anderson, Deloitte here. Former Alliance for a Stronger FDA (alumnus) and FasterCures... thanks for organizing this.
00:45:41	Thomas Seoh:	@Janet, I heard you at the CERSI Summit a few weeks ago and were impressed with your work on food and AI
00:45:54	Thomas Seoh:	was
01:16:34	Thomas Seoh:	@Tim:  did you say odds are good for extension of pediatric vouchers?  What is Steve, others, hearing?
01:17:26	VictoriaHorstman:	Victoria Horstman, MD PI, Care Access, Phoenix/Mesa Arizona. Thank you for this discussion
01:53:10	Thomas Seoh:	@Kelly:  2/28/25 we will present on the draft THRIVE Act
01:59:24	Thomas Seoh:	at CERSI, SVP Global Regulatory at Amgen reported they are getting 26 wks from data lock to BLA submission down to 8 wks by mid next yr.
01:59:43	Thomas Seoh:	using AI to write submission, CSRs etc.
02:01:54	Rashida Karmali:	Rashida Karmali, Dr. Woodcock thanks for defining "substantial evidence" in rare diseases, and the control arm-do you accept historical control when available? thank you
02:05:45	Fang Li:	Great panel discussion- second to Zan- Thanks to Dr Woodcock for her service to the country and humankind
02:05:50	Kanwaljit Singh:	Thank you all for hosting this amazing discussion. Such insight conversations, I liked how you focused on pediatric conditions as well. Best, Kanwaljit Singh
02:11:16	Jerry Colca:	Extension of regulatory exclusivity would be transformative for drugs/treatments that could impact broad outcomes.
02:15:36	David Wood:	What's the best link for info about the THRIVE act that was mentioned?
(The same name seems to already apply to other acts.)
02:16:40	Thomas Seoh:	@David:  all registrants to today's webinar will get notice and registration link.
02:27:19	Melissa King:	“Regulated”
02:36:35	Jade Byrd:	Thank you so much
02:36:48	kellyclose:	Thank you very much!! Phenomenal!
02:36:49	Melissa King:	Thank you!